Modulo Bio, Inc. Press Releases - EIN Presswire - Press Release Distribution Service

Published on September 22, 2025 - 13:00 GMT

Modulo Bio Joins Lilly Gateway Labs to Accelerate Development of Neuroimmune Therapies for ALS, FTD and Alzheimer's

Lilly partnership provides infrastructure to advance platform-discovered therapies targeting neurodegeneration SAN DIEGO, CA, UNITED STATES, September 22, 2025 /⁨EINPresswire.com⁩/ -- Modulo Bio, a biotechnology company developing therapies that reprogram …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 2, 2025 - 13:00 GMT

Modulo Bio Strengthens Board of Directors with Addition of Biopharma Veterans Nicholas Saccomano and Edmund Harrigan

Industry leaders bring decades of CNS drug development and regulatory expertise to advance company's neurodegenerative disease programs SAN DIEGO, CA, UNITED STATES, July 2, 2025 /⁨EINPresswire.com⁩/ -- Modulo Bio, a biotechnology company developing …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on June 3, 2025 - 12:00 GMT

Modulo Bio Appoints Biotechnology Veteran Joseph Wagner, Ph.D., as Chief Development Officer

Industry leader brings 25+ years of experience in therapeutic development and precision medicine to advance company's neurodegenerative disease programs SAN DIEGO, CA, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Modulo Bio, a biotechnology …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 19, 2025 - 11:00 GMT

Modulo Bio Announces $4.8M Strategic Investment by the Alzheimer’s Drug Discovery Foundation (ADDF)

Funds will help support the development of MOD 001, a neuroimmune system modulator SAN DIEGO, CA, UNITED STATES, March 19, 2025 /⁨EINPresswire.com⁩/ -- Modulo Bio, a company reprogramming the brain's immune system, announced today that it has received …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 7, 2025 - 13:00 GMT

Modulo Bio Awarded $500,000 Grant from the ALS Association to Advance Novel Therapeutic

Funds will support IND enabling activities paving the way for clinical trials in ALS and Frontotemporal Dementia SAN DIEGO, CA, UNITED STATES, February 7, 2025 /⁨EINPresswire.com⁩/ -- Modulo Bio announced today that it has received a $500,000 research …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...